Clinical Trial Update: Vemurafenib and TIL Therapy for Metastatic Melanoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update evaluating vemurafenib in combination with tumor-infiltrating lymphocyte (TIL) therapy for metastatic melanoma has completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Vemurafenib (vemurafenib)

Snippet

Sponsor: Inge Marie Svane | Conditions: Metastatic Melanoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-02-24